AMP Biotech 4Q16 Binary Events


AMP Biopharma provides analysis for upcoming company events that will impact company price. We sift through all biotech company drivers in each quarter to identify companies with the best risk/reward scenarios and provide those analyses for you. Each company we discuss will have an associated link to our evaluation.

The group of companies for this quarter are Ophthotech (OPHT), UniQure (QURE), and CytRx (CYTR).

OPHT: Ph3 Fovista data in patients with wet AMD

QURE: Ph1/2 AMT-060 high dose cohort data in patients with Hemophilia B

CYTR: Additional Ph3 Aldoxorubicin data in patients with soft tissue sarcomas


*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon